
# Mohan-Taylor-Lakhani Tool for Diabetes Remission Eligibility

> Based on Research by: Dr Roy Taylor and Dr. V. Mohan  
> Developed by: [Dr. Om J Lakhani]

## Overview

This tool helps determine if a patient is eligible for diabetes remission (colloquially called 'Diabetes reversal') based on the DiRECT study by Roy Taylor and Cluster classification by Dr. V. Mohan.

## Frequently Asked Questions

### What is diabetes remission?
Please see the notes on Diabetes Remission [here](https://www.endocrinology.co.in/notes-in-endocrinology/diabetes/newer-therapies-for-diabetes-management/diabetes-remission/).

### Who is this tool meant for?
This tool is only meant for adult patients with newly diagnosed diabetes mellitus.

### Is this tool clinically validated?
No, this tool has not been clinically validated.

### Is this tool patented?
- No
- This is an open source initiative
- You can find the code and the logic used for the tool on [GitHub](https://github.com/endocrinologyindia/diabetesremissioncalculator)

### What algorithm is used in the tool?
The algorithm can be found ![Algorithm](https://www.endocrinology.co.in/img/user/attachments/Pasted%20image%2020250107080829.png)

## Citations

1. Anjana RM, Pradeepa R, Unnikrishnan R, Tiwaskar M, Aravind SR, Saboo B, Joshi SR, Mohan V. New and unique clusters of type 2 diabetes identified in Indians. J Assoc Physicians India. 2021 Feb 1;69(2):58-61.

2. Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, Peters C, Zhyzhneuskaya S, Al-Mrabeh A, Hollingsworth KG, Rodrigues AM. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. The Lancet. 2018 Feb 10;391(10120):541-51.

3. Lakhani OJ, Gupta A, Tripathi P, Mehta C. An alpha-test of Diabetology. co. inâ€”an algorithm-driven personalized and precision medicine prescription system for treatment-naive patients with type 2 diabetes. International Journal of Diabetes in Developing Countries. 2024 Jun 29:1-0.
